Table 3 Severity of dysmenorrhoeic pain during treatment compared to the baseline levels

From: A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial

Visit Month 1*
n (%)
Month 2
n (%)
Month 3
n (%)
Month 4#
n (%)
Month 5
n (%)
Month 6
n (%)
Severity vs baseline EE/CMA EE/DRSP EE/CMA EE/DRSP EE/CMA EE/DRSP EE/CMA EE/DRSP EE/CMA EE/DRSP EE/CMA EE/DRSP
Much Decrease 49 (55.1) 32 (36.4) 53 (59.6) 41 (46.1) 64 (71.9) 58 (65.2) 82 (92.1) 72 (80.9) 88 (98.9) 85 (95.5) 86 (96.6) 85 (95.5)
Decrease 14 (15.7) 14 (15.9) 29 (32.6) 31 (34.8) 23 (25.8) 26 (29.2) 7 (7.9) 15 (16.9) 1 (1.1) 3 (3.4) 2 (2.2) 4 (4.5)
Not Change 22 (24.7) 40 (45.5) 7 (7.9) 16 (18) 2 (2.2) 3 (3.4) 0 (0) 2 (2.2) 0 (0) 1 (1.1) 1 (1.1) 0 (0)
Increase 4 (4.5) 2 (2.3) 0 (0) 1 (1.1) 0 (0) 2 (2.2) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
  1. *p = 0.013; p = 0.029; #p = 0.026; EE/CMA vs EE/DRSP